Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids

NCT05330078 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT05330078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05330078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids
Lead sponsor
University of California, San Diego
Phase
Phase 1
Overall status
Completed
Start date
March 11, 2022
Completion date
May 31, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

keloid